OFDT Nouveaut�s mensuelles

Advocating for needle and syringe exchange programmes in prisons / IHRA

Thu, 3 May 2012 15:58:02 +0100

Advocating for needle and syringe exchange programmes in prisons [Rapport] / IHRA . - IHRA (Harm Reduction International), 2012 . - 4 p.. - (Evidence and advocacy briefings series) .
Langues : Anglais (eng)

Cat�gories :	Th�saurus TOXIBASE ECHANGE DE SERINGUES ; EFFICACITE ; PRISON ; PROGRAMME ; REDUCTION DES RISQUES Th�saurus G�ographique INTERNATIONAL
Index. d�cimale :	PRE Prévention / Prevention
R�sum� :	Imprisonment is a common experience for people who use drugs. Approximately 56-90% of people who use drugs will spend time in prisons for a variety of crimes including drug use, possession, trafficking and sale, as well as for acquisitive crimes committed to support drug use. In many countries around the world, the growth of prison populations and resulting overcrowding has been attributed to the police campaigns to arrest and prosecute drug offenders. Evidence-based prison health programmes, including harm reduction interventions such as needle and syringe programmes (NSPs) and opioid substitution therapy (OST), significantly reduce drug-related harms among vulnerable populations. Since the early 1990s, an increasing number of countries have introduced these interventions to reduce HIV and HCV in prisons. iii However, the acceptance of harm reduction measures in places of detention has been difficult in most countries. This is often linked to the assumption on the part of policy-makers that such interventions are unsafe or inappropriate in closed environments. This briefing provides answers to some of the most commonly encountered questions when advocating for harm reduction in prisons and places of detention.
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Sous-type de document :	Lettre d'information / Newsletter
Refs biblio. :	17
En ligne :	http://www.ihra.net/contents/1192
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69558

Alcohol in the European Union. Consumption, harm and policy approaches / P. ANDERSON ; L. MOLLER ; G. GALEA

Wed, 2 May 2012 13:59:56 +0100

Alcohol in the European Union. Consumption, harm and policy approaches = (L'alcool dans l'Union europ�enne. Consommation, nocivit� et strat�gies adopt�es) [Rapport] / P. ANDERSON, Directeur de publication, r�dacteur en chef ; L. MOLLER, Directeur de publication, r�dacteur en chef ; G. GALEA, Directeur de publication, r�dacteur en chef . - Copenhagen : WHO Regional Office for Europe, 2012 . - 161 p. : ill., graph., tabl., ann.
ISBN : 978-92-89002-64-6
Langues : Anglais (eng)

Cat�gories :	Th�saurus TOXIBASE ABUS ; ACTION COMMUNAUTAIRE ; ALCOOL ; AVERTISSEMENT SANITAIRE ; CONSOMMATION ; DIFFUSION DES PRODUITS ; EDUCATION POUR LA SANTE ; EFFICACITE ; MILIEU PROFESSIONNEL ; MORBIDITE ; POLITIQUE ; PREVENTION ; PRIX ; PUBLICITE ; SANTE PUBLIQUE Th�saurus G�ographique EUROPE ; UNION EUROPEENNE
Index. d�cimale :	SAN Santé publique / Public health
R�sum� :	FRAN�AIS : Les informations r�unies en 2011 ont permis d'actualiser dans ce nouveau rapport les indicateurs cl�s sur la consommation d'alcool, sur les r�sultats obtenus en mati�re de sant� et sur les mesures visant � r�duire les d�g�ts provoqu�s par l'alcool dans toute l'Union europ�enne (UE). Ce rapport fait le survol des �tudes les plus r�centes sur les strat�gies efficaces en mati�re d'alcool, et comprend des donn�es de l'UE, de Norv�ge et de Suisse sur la consommation d'alcool, la nocivit� de l'alcool et les strat�gies pouvant �tre adopt�es en la mati�re. Ces donn�es ont �t� recueillies lors d'une enqu�te de 2011 effectu�e dans le cadre d'un projet de la Commission europ�enne et du Bureau r�gional de l'OMS pour l'Europe. Ce rapport met � jour les bases factuelles relatives � certains aspects importants des politiques concernant l'alcool, et fournit aux d�cideurs politiques et aux autres intervenants qui s'emploient � limiter l'impact n�gatif d'une consommation excessive d'alcool sur la sant� et sur la soci�t� des informations dont ils pourront s'inspirer pour agir � l'avenir. L'alcool constitue l'un des trois axes prioritaires de la sant� publique � l'�chelle mondiale. Quoique seule la moiti� de la population mondiale consomme de l'alcool, celui-ci est la troisi�me cause mondiale de morbidit� et de mortalit� pr�matur�e, apr�s le d�ficit pond�ral � la naissance et les rapports sexuels non prot�g�s. En Europe, l'alcool est le troisi�me facteur de risque de maladie et de d�c�s apr�s le tabagisme et l'hypertension art�rielle. ENGLISH: This new report uses information gathered in 2011 to update key indicators on alcohol consumption, health outcomes and action to reduce harm across the European Union (EU). It gives an overview of the latest research on effective alcohol policies, and includes data from the EU, Norway and Switzerland on alcohol consumption, harm and policy approaches. The data were collected from a 2011 survey, carried out as part of a project of the European Commission and the WHO Regional Office for Europe. The report updates the evidence base for some important areas of alcohol policy, and provides policy-makers and other stakeholders in reducing the harm done to health and society by excessive drinking with useful information to guide future action. Alcohol is one of the world's top three priority areas in public health. Even though only half the global population drinks alcohol, it is the world's third leading cause of ill health and premature death, after low birth weight and unsafe sex. In Europe, alcohol is the third leading risk factor for disease and death after tobacco and high blood pressure.
Domaine Toxibase :	Alcool. Alcohol.
Affiliation :	Institute of Health and Society, Newcastle University, United Kingdom
En ligne :	http://www.euro.who.int/fr/what-we-publish/abstracts/alcohol-in-the-european-uni [...]
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69535

Barom�tre de la consommation des boissons alcoolis�es 2012 / Entreprise & Pr�vention

Thu, 3 May 2012 15:44:44 +0100

Barom�tre de la consommation des boissons alcoolis�es 2012 [Rapport] / Entreprise & Pr�vention . - Paris : Entreprise & Pr�vention, 2012 . - 19 p. : graph.
Langues : Fran�ais (fre)

Cat�gories :	Th�saurus TOXIBASE ACHAT ; ALCOOL ; BOISSON ALCOOLIQUE ; CONSOMMATION ; DEBIT DE BOISSONS ; ENQUETE ; RESTAURANT Th�saurus G�ographique FRANCE
Index. d�cimale :	EPI Epidémiologie / Epidemiology
R�sum� :	Ce Barom�tre de la consommation des boissons alcoolis�es en France int�gre pour la premi�re fois une analyse de la consommation hors domicile. Il r�v�le que seulement 45 % des clients des caf�s, bars et restaurants y consomment des boissons alcoolis�es. Il s'agit surtout des plus de 45 ans qui repr�sentent 51 % des consommateurs. Plus globalement, la tendance vers une consommation plus occasionnelle se confirme, avec moins de consommateurs quotidiens (14 %). Dans les grandes surfaces, les Fran�ais ach�tent moins de boissons alcoolis�es mais y consacrent un budget plus important.
Domaine Toxibase :	Alcool. Alcohol.
Affiliation :	Paris, France
En ligne :	http://www.preventionalcool.com/index.php?/presse-et-publications/communiques-de [...]
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69556

G�opolitique des oc�ans. L'Eldorado maritime / C. P. COUTANSAIS

Thu, 3 May 2012 11:03:07 +0100

G�opolitique des oc�ans. L'Eldorado maritime [Livre] / C. P. COUTANSAIS, Auteur ; F. THUAL, Pr�facier, etc. . - Paris : Ellipses Marketing, 2012 . - 240 p.
ISBN : 978-2-7298-7235-9
Langues : Fran�ais (fre)

Cat�gories :	Th�saurus TOXIBASE CRIMINALITE ; GEOPOLITIQUE ; MARCHE DE LA DROGUE ; MONDIALISATION ; ORGANISATION CRIMINELLE ; TRAFIC INTERNATIONAL ; TRANSPORT MARITIME Th�saurus G�ographique INTERNATIONAL
Index. d�cimale :	MAR Marché de la drogue / Drug market
R�sum� :	Longtemps cantonn�e � des activit�s imm�moriales, l'exploitation des oc�ans se trouve d�sormais � un tournant : les hydrocarbures, les ressources min�rales et g�n�tiques, autant que les milliers de porte-conteneurs qui sillonnent la plan�te globalis�e, font de la mer un v�ritable Eldorado. Un Eldorado qui est pourtant loin d'�tre un paradis : du narcotrafic � la traite d'�tres humains en passant par la piraterie, la criminalit� internationale emprunte largement les chemins maritimes. La nouvelle g�opolitique des oc�ans est aussi celle de la nouvelle multipolarit�. Pour l'instant incontest�e, l'US Navy voit monter les ambitions maritimes de la Chine et de l'Inde, et le retour de la marine russe, tandis que les nations europ�ennes sont menac�es, elles, de d�classement. Les grands enjeux g�opolitiques de demain sont pourtant largement maritimes : des risques de conflits de d�limitation des zones maritimes qui regorgent de ressources jusqu'aux vell�it�s de contr�le des routes strat�giques, l'avenir se jouera en mer.
Note de contenu :	SOMMAIRE : � UN CADRE GÉOPOLITIQUE BOULEVERSÉ Un trésor minéral, biologique et énergétique La mer au coeur de la globalisation Les routes commerciales et stratégiques, entre permanence et nouveauté Les frontières maritimes en recomposition � LA MER AU COEUR DE L'EXPANSION DE LA CRIMINALITÉ TRANSNATIONALE L'irrésistible expansion du trafic de drogue ? La traite d'êtres humains, un commerce lucratif Le retour des frères de la Côte Le terrorisme n'a pas le pied marin � MARINES MILITAIRES : UNE REDISTRIBUTION DES CARTES L'art de la guerre navale à un tournant L'Empire américain : de la rupture stratégique à l'équilibre des forces Marines émergentes : des ambitions régionales et planétaires La Grande Europe, entre déclin et sursaut
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Affiliation :	France
Cote :	L01910
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69545

How profitable is methamphetamine dealing in Australia? / W. GONG ; A. RITTER ; D. BRIGHT ; C. DORAN in Drug and Alcohol Dependence, Vol.122, n�3 (May 2012)

Wed, 9 May 2012 11:47:05 +0100

How profitable is methamphetamine dealing in Australia? [P�riodique] / W. GONG ; A. RITTER ; D. BRIGHT ; C. DORAN . - 2012 . - 208-212.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.122, n�3 (May 2012) . - 208-212

Cat�gories :	Th�saurus TOXIBASE ECONOMIE PARALLELE ; EPIDEMIOLOGIE ANALYTIQUE ; METHAMPHETAMINE ; PRIX ; REVENDEUR
Index. d�cimale :	MAR Marché de la drogue / Drug market
R�sum� :	INTRODUCTION. The illicit drug trade is the largest in value among global illicit commodities, at some $320 billion US dollars, according to the UN World Drug Report. Endeavours to control such a large illicit market would be enhanced by improved understanding of the economics of the trade. However, due to its illicit nature many aspects of the illicit drug market are largely unknown. This study explored one economic aspect of illicit drug dealing, profitability, with the aim of developing a better picture of the financial gains from illicit drug dealing. METHODS. Data were obtained from judges sentencing remarks, key informants from law enforcement, and other published reports which detail the prices paid for methamphetamine in Australia. The financial margins attained from non-crystal methamphetamine dealing in Australia were calculated by examining the best fit for the relationship between prices and quantities: in this case a power law. RESULTS. If it is assumed that a single deal is divided (�cut�) between 4 times and 20 times before selling to the next customer, the mark-ups can range from 24% to 59%. The mark-ups appear low compared with those found in US research, but similar to those found in UK research. CONCLUSIONS. To our knowledge, this is the first attempt to analyse profitability of methamphetamine dealing in Australia. The findings of this study will help in understanding the motivations and decisions of drug dealers, and potentially assist drug law enforcement agencies to design better strategies to dismantle supply chain linkages which generate excessive profits.
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Refs biblio. :	36
Affiliation :	University of New South Wales, Sydney, New South Wales, Australie
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69572

Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids / R. DANIULAITYTE ; R. FALCK ; R. G. CARLSON in Drug and Alcohol Dependence, Vol.122, n�3 (May 2012)

Wed, 9 May 2012 11:39:39 +0100

Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids [P�riodique] / R. DANIULAITYTE ; R. FALCK ; R. G. CARLSON . - 2012 . - 201-207.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.122, n�3 (May 2012) . - 201-207

Cat�gories :	Th�saurus TOXIBASE BUPRENORPHINE ; EFFET RECHERCHE ; ETUDE QUALITATIVE ; PROFIL SOCIO-DEMOGRAPHIQUE ; USAGE DETOURNE ; USAGER Th�saurus G�ographique ETATS-UNIS
Index. d�cimale :	MAR Marché de la drogue / Drug market
R�sum� :	BACKGROUND. There is growing evidence about illicit use of buprenorphine in the U.S. The study aims to: (1) identify prevalence and predictors of illicit buprenorphine use in a community sample of 396 young adult (18�23 years old) non-medical users of pharmaceutical opioids and (2) describe knowledge, attitudes and behaviors linked to illicit buprenorphine use as reported by a qualitative sub-sample (n = 51). METHODS. Participants were recruited using respondent-driven sampling. Qualitative interview participants were selected from the larger sample. The sample (n = 396) was 54% male and 50% white; 7.8% reported lifetime illicit use of buprenorphine. RESULTS. Logistic regression analysis results indicate that white ethnicity, intranasal inhalation of pharmaceutical opioids, symptoms of opioid dependence, and a greater number of pharmaceutical opioids used in lifetime were statistically significant predictors of illicit buprenorphine use. Qualitative interviews revealed that buprenorphine was more commonly used by more experienced users who were introduced to it by their "junkie friends." Those who used buprenorphine to self-medicate withdrawal referred to it as a "miracle pill." When used to get high, reported experiences ranged from "the best high ever" to "puking for days." Participants reported using buprenorphine/naloxone orally or by intranasal inhalation. Injection of buprenorphine without naloxone was also reported. CONCLUSION. Our findings suggest that illicit buprenorphine use is gaining ground primarily among whites and those who are more advanced in their drug use careers. Continued monitoring is needed to better understand evolving patterns and trends of illicit buprenorphine use.
Domaine Toxibase :	Autres substances addictives
Refs biblio. :	52
Affiliation :	Center for Interventions, Treatment, and Addictions Research, Department of Community Health, Boonshoft School of Medicine, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435, USA
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69571

Mortality attributable to tobacco. WHO global report / OMS / WHO

Wed, 2 May 2012 14:32:07 +0100

Titre pr�c�dent Global health risks. Mortality and burden of disease attributable to selected major risks / OMS / WHO

Mortality attributable to tobacco. WHO global report [Rapport] / OMS / WHO . - Geneva : WHO, 2012 . - 396 p. : tabl., graph.
ISBN : 978-92-415-6443-4
Langues : Anglais (eng)

Cat�gories :	Th�saurus TOXIBASE CAUSE DE DECES ; EPIDEMIOLOGIE ; MORTALITE ; TABAC Th�saurus G�ographique INTERNATIONAL
Index. d�cimale :	EPI Epidémiologie / Epidemiology
R�sum� :	FRAN�AIS : Ce rapport pr�sente sous forme de fiches, par continent, par zone g�ographique et par pays, les taux de mortalit� attribuables au tabac par cat�gorie d'�ge et par sexe, prenant en compte les maladies transmissibles (tuberculose et autres maladies infectieuses) et non transmissibles (cancers, maladies cardio-vasculaires, maladies du syst�me respiratoire�). Chaque fiche pr�sente des tableaux comprenant les taux de mortalit� imputables � la consommation de tabac ainsi que la part des d�c�s due au tabac selon chacune des maladies. Afin de contextualiser ces chiffres, un rappel des donn�es d�mographiques g�n�rales (r�partition de la population par �ge et par sexe) est propos� pour chaque fiche. Les auteurs rappellent que 12 % des d�c�s chez les personnes de 30 ans et plus dans le monde sont attribuables � la consommation de tabac et que 5 millions de personnes dans cette cat�gorie d'�ge sont d�c�d�es suite � la consommation directe de tabac en 2004. ENGLISH: This report provides information by country on the proportion of adult (age 30 years and above) deaths attributable to tobacco by major communicable and non-communicable causes by age and sex. It builds and is consistent with the global estimate provided in WHO's 2009 report entitled "Global health risks: mortality and burden of disease attributable to selected major risks".
Domaine Toxibase :	Tabac. Tobacco.
Refs biblio. :	21
En ligne :	http://www.who.int/tobacco/publications/surveillance/rep_mortality_attibutable/e [...]
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69536

Neonatal abstinence syndrome and associated health care expenditures / S. W. PATRICK ; R. E. SCHUMACHER ; B. D. BENNEYWORTH ; E. E. KRANS ; J. M. McALLISTER ; M. M. DAVIS in Journal of the American Medical Association, Vol.307, n�18 (May 9, 2012)

Thu, 10 May 2012 15:54:55 +0100

Neonatal abstinence syndrome and associated health care expenditures [P�riodique] / S. W. PATRICK ; R. E. SCHUMACHER ; B. D. BENNEYWORTH ; E. E. KRANS ; J. M. McALLISTER ; M. M. DAVIS . - 2012 . - 1934-1940.
Editorial: Epidemic of prescription opiate abuse and neonatal abstinence. Hayes M.J., Brown M.S., p. 1974-1975.
Langues : Anglais (eng)
in Journal of the American Medical Association > Vol.307, n�18 (May 9, 2012) . - 1934-1940

Cat�gories :

Th�saurus TOXIBASE
DEPENSES DE SANTE ; DIAGNOSTIC ; ENFANT D'USAGER ; ETUDE RETROSPECTIVE ; EVOLUTION ; INCIDENCE ; NOUVEAU NE ; OPIACES ; SYNDROME DE SEVRAGE
Th�saurus G�ographique
ETATS-UNIS

Index. d�cimale :

EPI Epidémiologie / Epidemiology

R�sum� :

Context: Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome primarily caused by maternal opiate use. No national estimates are available for the incidence of maternal opiate use at the time of delivery or NAS.
Objectives: To determine the national incidence of NAS and antepartum maternal opiate use and to characterize trends in national health care expenditures associated with NAS between 2000 and 2009.
Design, Setting, and Patients: A retrospective, serial, cross-sectional analysis of a nationally representative sample of newborns with NAS. The Kids' Inpatient Database (KID) was used to identify newborns with NAS by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code. The Nationwide Inpatient Sample (NIS) was used to identify mothers using diagnosis related groups for vaginal and cesarean deliveries. Clinical conditions were identified using ICD-9-CM diagnosis codes. NAS and maternal opiate use were described as an annual frequency per 1000 hospital births. Missing hospital charges (

Piperazine compounds as drugs of abuse / M. D. ARBO ; M. L. BASTOS ; H. F. CARMO in Drug and Alcohol Dependence, Vol.122, n�3 (May 2012)

Wed, 9 May 2012 11:30:39 +0100

Piperazine compounds as drugs of abuse [P�riodique] / M. D. ARBO ; M. L. BASTOS ; H. F. CARMO . - 2012 . - 174-185.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.122, n�3 (May 2012) . - 174-185

Cat�gories :	Th�saurus TOXIBASE ANALYSE CHIMIQUE ; DROGUES DE SYNTHESE ; EFFET SECONDAIRE ; MECANISME D'ACTION ; PHARMACOCINETIQUE ; PIPERAZINE
Index. d�cimale :	PRO Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods
R�sum� :	Synthetic drugs are among the most commonly abused drugs in the world. This abuse is widespread among young people, especially in the dance club and rave scenes. Over the last several years, piperazine derived drugs have appeared, mainly available via the internet, and sold as ecstasy pills or under the names of "Frenzy", "Bliss", "Charge", "Herbal ecstasy", "A2", "Legal X" and "Legal E". Although in the market piperazine designer drugs have the reputation of being safe, several experimental and epidemiological studies indicate risks for humans. Piperazine designer drugs can be divided into two classes, the benzylpiperazines such as N-benzylpiperazine (BZP) and its methylenedioxy analogue 1-(3,4-methylenedioxybenzyl)piperazine (MDBP), and the phenylpiperazines such as 1-(3-chlorophenyl)piperazine (mCPP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP), and 1-(4-methoxyphenyl)piperazine (MeOPP). Toxicokinetic properties, including metabolic pathways, actions and effects in animals and humans, with some hypothesis of mechanism of action, and analytical approaches for the identification of these drugs are summarized in this review.
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Sous-type de document :	Revue de la littérature / Literature review
Refs biblio. :	63
Affiliation :	REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Aníbal Cunha 164, 4099-030 Porto, Portugal
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69570

Strategies for evaluating the economic value of drugs in alcohol dependence treatment / D. SCHWAPPACH ; S. POPOVA ; S. MOHAPATRA ; J. PATRA ; A. GODINHO ; J. REHM in Drug and Alcohol Dependence, Vol.122, n�3 (May 2012)

Wed, 9 May 2012 11:00:13 +0100

Strategies for evaluating the economic value of drugs in alcohol dependence treatment [P�riodique] / D. SCHWAPPACH ; S. POPOVA ; S. MOHAPATRA ; J. PATRA ; A. GODINHO ; J. REHM . - 2012 . - 165-173.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.122, n�3 (May 2012) . - 165-173

Cat�gories :	Th�saurus TOXIBASE ACAMPROSATE ; ALCOOL ; COUT ; COUT SOCIAL ; DISULFIRAM ; EFFICACITE ; EPIDEMIOLOGIE ANALYTIQUE ; NALTREXONE ; TRAITEMENT Th�saurus G�ographique ALLEMAGNE ; AUSTRALIE ; BELGIQUE ; ESPAGNE ; ETATS-UNIS
Index. d�cimale :	TRA Traitement et prise en charge / Treatment and care
R�sum� :	BACKGROUND. To assess existing health economic strategies, which are used to evaluate the economic value of drugs to treat alcohol dependence (AD) such as acamprosate, naltrexone and any other pharmaceuticals. METHODS. A systematic literature search on AD treatment economic evaluation studies was performed in multiple electronic bibliographic and economic databases. RESULTS. A total of seven studies were found that involved economic evaluations of pharmacotherapy treatment of AD. It was seen that all individual pharmacotherapy treatment programs including acamprosate, naltrexone and combined treatments have resulted in a net benefit or cost savings. However, the examined studies used different methods to estimate the costs, cost savings, and cost effectiveness of the treatments. CONCLUSIONS. Pharmacotherapy treatment of AD produced marked economic benefits. However, the number of studies on the economic evaluation of pharmacotherapy for AD treatment is limited. The gaps in these studies have also been identified as necessitating more research.
Domaine Toxibase :	Alcool. Alcohol.
Sous-type de document :	Revue de la littérature / Literature review
Refs biblio. :	34
Affiliation :	Research Institute for Public Health and Addiction, WHO Collaborating Centre for Substance Abuse, Suisse
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69569

The Reitox network: frequently asked questions / OEDT = EMCDDA (Lisbonne, Portugal)

Wed, 2 May 2012 15:09:14 +0100

The Reitox network: frequently asked questions [Brochure] / OEDT = EMCDDA (Lisbonne, Portugal) . - Luxembourg : Publications Office of the European Union : Lisbon : OEDT / EMCDDA, 2012 . - 12 p.
ISBN : 978-92-916848-8-5
Langues : Anglais (eng)

Cat�gories :	Th�saurus TOXIBASE INFORMATION ; SURVEILLANCE EPIDEMIOLOGIQUE Th�saurus G�ographique EUROPE Organismes OEDT
Index. d�cimale :	EPI Epidémiologie / Epidemiology
R�sum� :	This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. Compiled over several years, it is a reference tool for both EU Member States and countries further afield on the network, its members, its role and development.
Note de contenu :	TABLE OF CONTENTS: � What is Reitox? � Who are members of the Reitox network? � What is the Reitox network�s main mission? � Is there a difference between a national focal point and a national drugs observatory? � What are the functions of Reitox national focal points at European level? � What are the functions of Reitox national focal points at national level? � How is Reitox managed? � How should a national focal point be structured? � What types of information should Reitox members provide to the EMCDDA and when? � How many staff members should work in a national focal point and what qualifications do they need? � How are Reitox national focal points financed? � What is the �Reitox Academy�? � Who can benefit from Reitox national focal points� expertise at national level and how? � What is the added value in joining the Reitox network for non‐EU countries? � How can my country join the Reitox network? � Where can I find the contact details for Reitox members?
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Cote :	OEDT-20.5
En ligne :	http://www.emcdda.europa.eu/publications/brochures/rtxfaq
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69537

TRACFIN et la lutte contre le blanchiment d'argent. (Rapport public annuel 2012) / Cour des comptes

Thu, 3 May 2012 15:48:51 +0100

TRACFIN et la lutte contre le blanchiment d'argent. (Rapport public annuel 2012) = (TRACFIN and combatting money laundering) [Chapitre] / Cour des comptes . - Paris : Cour des Comptes, 2012 . - 197-228.
Langues : Anglais (eng) Fran�ais (fre)

Cat�gories :	Th�saurus TOXIBASE BANQUE ; BLANCHIMENT ; DEFINITION ; EVALUATION ; FILIERE ; FINANCEMENT ; LUTTE ; POLITIQUE ; SAISIE ; SANCTION PENALE
Index. d�cimale :	LOI Loi et son application / Law enforcement
R�sum� :	Dans un contexte o� la communaut� internationale (FMI et G20 notamment) associe stabilit� �conomique et financi�re � la mise en place de dispositifs solides de lutte contre le blanchiment des capitaux, la Cour dresse un bilan de l'action de TRACFIN. Elle apporte ainsi un �clairage compl�mentaire � ses travaux men�s par ailleurs sur la supervision et la r�gulation �conomique et financi�re. Le renforcement des missions confi�es � TRACFIN et l��largissement du champ d�claratif doivent conduire le service � renforcer ses analyses du ph�nom�ne, � approfondir ses relations avec les professions assujetties et � adapter sa structure et son organisation aux enjeux fondamentaux dont il a la charge. (Extrait du document)
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Affiliation :	France
En ligne :	http://www.ccomptes.fr/fr/CC/Sommaire-27.html
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69557

Vol.122, n�3 - May 2012 (Bulletin de Drug and Alcohol Dependence)

Wed, 9 May 2012 10:51:11 +0100

est un bulletin de Drug and Alcohol Dependence

Vol.122, n�3 - May 2012 [P�riodique] . - 2012 . - 165-258.
Langues : Anglais (eng)

Note de contenu :	CONTENTS Reviews � Strategies for evaluating the economic value of drugs in alcohol dependence treatment, Pages 165-173, David Schwappach, Svetlana Popova, Satya Mohapatra, Jayadeep Patra, Alexandra Godinho, Jürgen Rehm � Piperazine compounds as drugs of abuse, Pages 174-185, M.D. Arbo, M.L. Bastos, H.F. Carmo Full Length Reports � Intensive intervention for alcohol-dependent smokers in early recovery: A randomized trial, Pages 186-194, Timothy P. Carmody, Kevin Delucchi, Carol L. Duncan, Peter Banys, Joel A. Simon, Sharon N. Solkowitz, Joy Huggins, Sharon K. Lee, Sharon M. Hall � Individual-level syringe coverage among Needle and Syringe Program attendees in Australia, Pages 195-200, Jenny Iversen, Libby Topp, Handan Wand, Lisa Maher � Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids, Pages 201-207, Raminta Daniulaityte, Russel Falck, Robert G. Carlson � How profitable is methamphetamine dealing in Australia?, Pages 208-212, Wendy Gong, Alison Ritter, David Bright, Chris Doran � Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes, Pages 213-219, L.M. Jansson, J.A. Di Pietro, A. Elko, E.L. Williams, L. Milio, M. Velez � Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors, Pages 220-227, P.T. Harrell, B.E. Mancha, H. Petras, R.C. Trenz, W.W. Latimer � A preliminary study of the neural effects of behavioral therapy for substance use disorders, Pages 228-235, Elise E. DeVito, Patrick D. Worhunsky, Kathleen M. Carroll, Bruce J. Rounsaville, Hedy Kober, Marc N. Potenza � The Physicians� Competence in Substance Abuse Test (P-CSAT): A multidimensional educational measurement tool for substance abuse training programs, Pages 236-240, John M. Harris Jr., Huaping Sun � Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors, Pages 241-246, Elizabeth M. Oliva, Alex H.S. Harris, Jodie A. Trafton, Adam J. Gordon Short Communications � Overexpression of α3/α5/β4 nicotinic receptor subunits modifies impulsive-like behavior, Pages 247-252, Xavier Viñals, Susanna Molas, Xavier Gallego, Rubén D. Fernández-Montes, Patricia Robledo, Mara Dierssen, Rafael Maldonado � Heart rate turbulence during acute alcohol withdrawal syndrome, Pages 253-257, Thomas Jochum, Steffen Schulz, Marion Schein, Rico Schröder, Andreas Voss, Karl-Jürgen Bär
En ligne :	http://www.sciencedirect.com/science/journal/03768716
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=bulletin_display&id=4105

Afghanistan opium survey. 2012. Opium risk assessment for all regions (Phase 1 & 2) / UNODC

Thu, 3 May 2012 16:14:06 +0100

Afghanistan opium survey. 2012. Opium risk assessment for all regions (Phase 1 & 2) [Rapport] / UNODC . - Vienne : UNODC, 2012 . - 33 p. : ill., graph., tabl.
Langues : Anglais (eng)

Cat�gories :	Th�saurus TOXIBASE ECONOMIE ; ENQUETE ; EVOLUTION ; GEOGRAPHIE ; OPIUM ; PRIX ; PRODUCTION ; SECURITE Th�saurus G�ographique AFGHANISTAN
Index. d�cimale :	MAR Marché de la drogue / Drug market
R�sum� :	In 2012, the Opium Risk Assessment is carried out in two phases similar to last year. The first phase was carried out in December 2011 and January 2012 and covered the Central, Eastern, Southern and Western region, where opium is sown in fall 2011. Confirming the findings of the 2011 Afghanistan Opium Survey, the Risk Assessment of this year indicated the strong association between insecurity, lack of agricultural assistance and opium cultivation. Villages with a low level of security and which had not received agricultural assistance in the previous year were significantly more likely to grow poppy in 2012 than villages with good security and those, which had received assistance. Similarly, villages which had been targeted by an anti-poppy awareness campaign were significantly less likely to grow poppy in 2012. [Extracts]
Domaine Toxibase :	Drogues illicites. Illicit drugs.
Affiliation :	Austria
En ligne :	http://www.unodc.org/unodc/en/crop-monitoring/index.html?tag=Afghanistan
Permalink :	http://bdoc.ofdt.fr/pmb/opac_css/index.php?lvl=notice_display&id=69560